Drug Pipeline

AdMSC Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04356755 Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. Systemic Sclerosis Recruiting
NCT07326033 Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell… Systemic Scleroderma Not Yet Recruiting
Phase 1/2
NCT06775964 Stem Cell Therapy for Early Alzheimer's Disease Cognitive Dysfunction Recruiting
Sponsors Running AdMSC Trials
University Hospital, Toulouse (2) Paul E Schulz (1)
Disease Areas
Scleroderma (2)
Get alerts when AdMSC trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free